Skip to main content Skip to navigation
CD38-APC-C750™
Product Details
Down Arrow Up Arrow


BD Cytognos™
CD38
Human
Mouse IgG1
Human B cell precursors, mature and memory B cells, plasma cells and plasmablasts, myeloid precursors, endothelial cells, mesenchymal cells, tumor-associated monocytes/macrophages
3 µl/test
Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
CE_IVD


cyt-38ac750 Rev. 1
Antibody Details
Down Arrow Up Arrow
LD38

CD38, clone M38, monoclonal antibody can be used for the identification of abnormal and normal/ reactive B cell precursors, of  mature B-cells in general and memory B-cells, and also normal and abnormal plasma cells and plasmablasts. CD38 clone M38 is also useful for the characterization of other cell subsets like myeloid precursors, endothelial cells, mesenchymal cells and tumour-associated monocytes/macrophages (TAMs).

cyt-38ac750 Rev. 1
Format Details
Down Arrow Up Arrow
APC-C750
APC-C750 is part of the BD red family of dyes. This fluorochrome has an excitation maximum (Ex Max) at 651-nm and an emission maximum (Em Max) at 779-nm. APC-C750 is designed to be excited by the Red laser (633, 635 nm) . Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.
APC-C750
Red 633 nm, 635 nm
651 nm
779 nm
cyt-38ac750 Rev.1
Citations & References
Down Arrow Up Arrow
View product citations for antibody "cyt-38ac750" on CiteAb
No Citations Found

No Citations are available for this Product

cyt-38ac750 Rev. 1

 

Please refer to Support Documents for Quality Certificates


Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described


Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.

For In Vitro Diagnostic Use.

 

23-22942-00

Documents are subject to revision without notice. Please verify you have the correct revision of the document, and always refer back to BD's eIFU website for the latest and most up to date information.